Formulation for menopausal women
First Claim
Patent Images
1. A composition for administration to premenopausal and menopausal women, which comprises:
- an essential fatty acid compound selected from the group consisting of a linoleic acid compound, a linolenic acid compound, a docosahexaenoic acid compound, an omega-3 fatty acid compound, an omega-2 fatty acid compound, a derivative thereof and a combination thereof in an amount of about 10 mg to about 1,000 mg;
a calcium compound or derivative thereof in an amount of about 400 mg to about 2500 mg;
a folic acid compound or derivative thereof in an amount of about 0.4 mg to about 5.0 mg; and
wherein the weight ratio of the essential fatty acid compound to the calcium compound or derivative thereof is about 1;
0.4 to 250.
0 Assignments
0 Petitions
Accused Products
Abstract
The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from symptoms associated with menopause, as well as prophylactic effects, and methods for using same.
-
Citations
101 Claims
-
1. A composition for administration to premenopausal and menopausal women, which comprises:
-
an essential fatty acid compound selected from the group consisting of a linoleic acid compound, a linolenic acid compound, a docosahexaenoic acid compound, an omega-3 fatty acid compound, an omega-2 fatty acid compound, a derivative thereof and a combination thereof in an amount of about 10 mg to about 1,000 mg;
a calcium compound or derivative thereof in an amount of about 400 mg to about 2500 mg;
a folic acid compound or derivative thereof in an amount of about 0.4 mg to about 5.0 mg; and
wherein the weight ratio of the essential fatty acid compound to the calcium compound or derivative thereof is about 1;
0.4 to 250. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)
-
-
40. A composition for administration to a menopausal woman, which comprises:
-
a first fatty acid compound selected from the group consisting of a linoleic acid compound, a derivative thereof and a combination thereof in an amount of about 10 mg to about 1,000 mg;
a second fatty acid compound selected from the group consisting of a linolenic acid compound, a derivative thereof and combinations thereof in an amount of about 10 mg to about 1,000 mg;
a third fatty acid compound selected from the group consisting of a docosahexaenoic acid compound, an omega-3 fatty acid, an omega-2 fatty acid, a derivative thereof and a combination thereof in an amount of about 10 mg to about 1,000 mg;
a calcium compound or derivative thereof in an amount of about 400 mg to about 2500 mg;
a folic acid compound or derivative thereof in an amount of about 0.4 mg to about 5.0 mg;
a vitamin C compound or derivative thereof in an amount of about 25 mg to about 500 mg;
a vitamin E compound or derivative thereof in an amount of about 10 mg to about 500 mg;
wherein the weight ratio of the sum of the amounts of said first and second fatty acid compounds to the amount of said third fatty acid compound is about 1;
0.5 to 1.5; and
wherein the weight ratio of the sum of the amounts of said first, second and third fatty acid compounds to the amount of said calcium compound or derivative thereof is about 1;
0.4 to 50. - View Dependent Claims (41, 42, 43, 44, 45, 46, 47, 48)
-
-
49. A composition for administration to a menopausal woman, which comprises:
-
a first fatty acid compound selected from the group consisting of a linoleic acid compound, a derivative thereof and a combination thereof in an amount of about 10 mg to about 1,000 mg;
a second fatty acid compound selected from the group consisting of a linolenic acid compound, a derivative thereof and combinations thereof in an amount of about 10 mg to about 1,000 mg;
a third fatty acid compound selected from the group consisting of a docosahexaenoic acid compound, an omega-3 fatty acid, an omega-2 fatty acid, a derivative thereof and a combination thereof in an amount of about 10 mg to about 1,000 mg;
a calcium compound or derivative thereof in an amount of about 400 mg to about 2500 mg;
a folic acid compound or derivative thereof in an amount of about 0.4 mg to about 5.0 mg;
a vitamin C compound or derivative thereof in an amount of about 25 mg to about 500 mg;
a vitamin E compound or derivative thereof in an amount of about 10 mg to about 500 mg;
a vitamin A compound or derivative thereof in an amount of about 2,500 IU to about 6,500 IU;
wherein the weight ratio of the sum of the amounts of said first and second fatty acid compounds to the amount of said third fatty acid compound is about 1;
0.5 to 1.5; and
wherein the weight ratio of the sum of said first, second and third fatty acid compounds to the amount of said calcium compound or derivative thereof is about 1;
0.4 to 50.
-
-
50. A composition for administration to a menopausal woman, which comprises:
-
a first fatty acid compound selected from the group consisting of a linoleic acid, compound, a derivative thereof and a combination thereof in an amount of about 10 mg to about 1,000 mg;
a second fatty acid compound selected from the group consisting of a linolenic acid compound, a derivative thereof and combinations thereof in an amount of about 10 mg to about 1,000 mg;
a third fatty acid compound selected from the group consisting of a docosahexaenoic acid compound, an omega-3 fatty acid, an omega-2 fatty acid, a derivative thereof and a combination thereof in an amount of about 10 mg to about 1,000 mg;
a calcium compound or derivative thereof in an amount of about 400 mg to about 2500 mg;
a folic acid compound or derivative thereof in an amount of about 0.4 mg to about 5.0 mg;
a vitamin C compound or ester derivative thereof in an amount of about 25 mg to about 500 mg;
a vitamin E compound or derivative thereof in an amount of about 10 mg to about 500 mg;
a vitamin B6 compound or derivative thereof in an amount of about 10 mg to about 50 mg;
a vitamin B12 compound or derivative thereof in an amount of about 25 mcg to about 75 mcg;
a vitamin D compound or derivative thereof in an amount of about 200 IU to about 625 IU;
wherein the weight ratio of the sum of the amounts of said first and second fatty acid compounds to the amount of said third fatty acid compound is about 1;
0.5 to 1.5; and
wherein the weight ratio of the sum of the amounts of said first, second and third fatty acid compounds to the amount of said calcium compound or derivative thereof is about 1;
0.4 to 50.
-
-
51. A composition for administration to a menopausal woman, which comprises:
-
a biologically active substance for treating symptoms of menopause;
a calcium compound or derivative thereof in an amount of about 400 mg to about 2500 mg;
a folic acid compound or derivative thereof in an amount of about 0.4 mg to about 5.0 mg. - View Dependent Claims (52, 53)
-
-
54. A drug delivery regimen, which comprises:
-
a first dosage form comprising a first biologically active substance to be administered to a menopausal woman at a predetermined time period;
a second dosage form comprising a second biologically active substance to be administered to the menopausal woman simultaneously with said first dosage form;
wherein said first biologically active substance and said second biologically active substance are incompatible substances. - View Dependent Claims (55, 56, 57, 58, 59, 60, 61, 62, 63, 64)
-
-
65. A method for providing nutritional supplementation to a menopausal woman, which comprises:
-
administering an essential fatty acid compound to the woman during the period commencing at the onset of perimenopause, said essential fatty acid compound being selected from the group consisting of a linoleic acid compound, a linolenic acid compound, a docosahexaenoic acid compound, an omega-3 fatty acid compound, an omega-2 fatty acid compound, a derivative thereof and a combination thereof;
administering about 400 mg to about 2500 mg of a calcium compound or derivative thereof to the woman during the period commencing at the onset of perimenopause;
administering about 0.4 mg to about 5.0 mg of a folic acid compound or derivative thereof to the woman during the period commencing at the onset of perimenopause; and
wherein the weight ratio of the essential fatty acid compound to the calcium compound or derivative thereof is about 1;
0.4 to 250. - View Dependent Claims (66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93)
-
-
94. A method for providing nutritional supplementation to a menopausal woman while reducing symptoms associated with menopause, which comprises:
-
administering a fatty acid compound to the woman during a period commencing at the onset of menopause, said fatty acid compound being selected from the group consisting of a linoleic acid compound, a linolenic acid compound, a docosahexaenoic acid compound, an omega-3 fatty acid, an omega-2 fatty acid, a derivative thereof and a combination thereof;
administering about 400 mg to 2500 mg of a calcium compound or derivative thereof to said woman; and
administering a non-nutritional active to said woman. - View Dependent Claims (95)
-
-
96. A method for providing nutritional supplementation to a menopausal woman while reducing symptoms associated with menopause, which comprises:
-
administering a first fatty acid compound to the woman during a period commencing at the onset of menopause, said first fatty acid compound being selected from the group consisting of a linoleic acid compound, a derivative thereof and a combination thereof;
administering a second fatty acid compound to said woman during the period commencing at the onset of menopause, said second fatty acid compound being selected from the group consisting of a linolenic acid compound, a derivative thereof and a combination thereof;
administering a third fatty acid compound to said woman during the period commencing at the onset of menopause, said third fatty acid compound being selected from the group consisting of a docosahexaenoic acid compound, an omega-3 fatty acid, an omega-2 fatty acid, a derivative thereof and a combination thereof, and said third fatty acid compound being provided to the woman together with said first and second fatty acid compounds;
administering about 400 mg to 2500 mg of a calcium compound or derivative thereof to said woman;
administering a non-nutritional active to said woman;
wherein the weight ratio of the sum of the amounts of said first and second fatty acid compounds to the amount of said third fatty acid compound is about 1;
0.5 to 1.5; and
wherein the weight ratio of the sum of said first, second and third fatty acid compound to the amount of said calcium compound or derivative thereof is about 1;
0.4 to 50. - View Dependent Claims (97, 98)
-
-
99. A method for delaying the onset of menopause, which comprises:
-
administering an essential fatty acid to a woman prior to menopause, said fatty acid being selected from the group consisting of a linoleic acid compound, a linolenic acid compound, a docosahexaenoic acid compound, an omega-3 fatty acid compound, an omega-2 fatty acid compound, a derivative thereof and a combination thereof;
wherein said essential fatty acid is administered in an amount sufficient to delay the onset of menopause.
-
-
100. A method for reducing the possibility of premature menopause, which comprises:
-
administering an essential fatty acid to a woman prior to menopause, said fatty acid being selected from the group consisting of a linoleic acid compound, a linolenic acid compound, a docosahexaenoic acid compound, an omega-3 fatty acid compound, an omega-2 fatty acid compound, a derivative thereof and a combination thereof;
wherein said essential fatty acid is administered in an amount sufficient to reduce the risk of premature menopause.
-
-
101. A method for providing nutritional supplementation to a premenopausal woman or a menopausal woman, which comprises:
-
administering to the premenopausal woman or menopausal woman a biologically active substance for treating symptoms of menopause;
administering to the premenopausal woman or menopausal woman a calcium compound or derivative thereof in an amount of 400 mg to about 2500; and
administering to the premenopausal woman or menopausal woman a folic acid compound or derivative thereof in an amount of about 0.4 mg to about 5.0 mg.
-
Specification